Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.41 |
| ▸ | PRKCG | P05129 | 2/20 | 0.41 |
| ▸ | PRKCB | P05771 | 2/20 | 0.41 |
| ▸ | PRKCA | P17252 | 2/20 | 0.41 |
| ▸ | PRKCH | P24723 | 2/20 | 0.41 |
| ▸ | PRKCI | P41743 | 2/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.41 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.41 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HLCS | P50747 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19297985 | 1.00 | — | — | |
| SCHEMBL5802259 | 1.00 | ALDH1A1 (0.58) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL51216 | 1.00 | ALDH1A1 (0.58) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL6431887 | 1.00 | ALDH1A1 (0.58) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL51708 | 1.00 | ALDH1A1 (0.58) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL9650577 | 1.00 | ALDH1A1 (0.58) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL19297986 | 1.00 | — | — | |
| SCHEMBL52306 | 1.00 | ALDH1A1 (0.58) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL11243835 | 1.00 | ALDH1A1 (0.58) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL2318247 | 1.00 | ALDH1A1 (0.58) | ALDH1A1PRKD3PRKCGPRKCBPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243220-A1 | ATR INHIBITORS | APREA THERAPEUTICS, INC. | 2025-07-31 | — | — | US | disclosed |
| EP-4507791-A1 | ATR INHIBITORS | Aprea Therapeutics, Inc. (US) | 2025-02-19 | — | — | EP | disclosed |
| US-20240148699-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-05-09 | — | — | US | disclosed |
| WO-2023201320-A1 | ATR INHIBITORS | Atrin Pharmaceuticals LLC (US) | 2023-10-19 | — | — | WO | disclosed |
| CN-109535707-B | Pneumatic tire | 横滨橡胶株式会社 | 2021-05-25 | — | — | CN | disclosed |
| EP-2508342-B1 | INNER LINER FOR PNEUMATIC TIRE, AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2020-04-01 | — | — | EP | disclosed |
| US-20200078340-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-03-12 | — | — | US | disclosed |
| EP-2508343-B1 | MULTILAYER STRUCTURE AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2020-03-11 | — | — | EP | disclosed |
| EP-2554372-B1 | MULTILAYERED STRUCTURE AND LAMINATE AND METHOD FOR PRODUCTION OF THE SAME | KURARAY CO (JP) | 2020-01-08 | — | — | EP | disclosed |
| EP-2857451-B1 | PNEUMATIC TIRE | YOKOHAMA RUBBER CO LTD (JP) | 2019-05-08 | — | — | EP | disclosed |
| EP-0739351-B1 | MONOMERIC DIOLS AND PHOSPHATE LINKED OLIGOMERS FORMED THEREFROM | ISIS PHARMACEUTICALS INC (US) | 2002-04-10 | — | — | EP | disclosed |
| EP-0673956-B1 | Binder for coating materials containing dispersed inorganic powder, coating material containing dispersed inorganic powder, and magnetic recording medium | NIPPON ZEON CO (JP) | 2000-01-05 | — | — | EP | disclosed |
| US-5886177-A | ETHYLENE GLYCOL MONOMERS JOINED VIA STANDARD PHOSPHATE LINKAGES INCLUDING PHOSPHOROTHIOATE, PHOSPHODIESTER, AND PHOSPHORAMIDATE LINKAGES; USEFUL FUNCTIONAL GROUPS INCLUDE NUCLEOBASES AS WELL AS POLAR GROUPS, HYDROPHOBIC GROUPS | ISIS PHARMACEUTICALS, INC. (US) | 1999-03-23 | — | — | US | disclosed |
| EP-0739351-A4 | MONOMERIC DIOLS AND PHOSPHATE LINKED OLIGOMERS FORMED THEREFROM | ISIS PHARMACEUTICALS INC (US) | 1998-10-21 | — | — | EP | disclosed |
| US-5607772-A | POLYURETHANE HAVING TERMINAL EPOXY GROUPS | NIPPON ZEON CO., LTD. (JP) | 1997-03-04 | — | — | US | disclosed |
| EP-0739351-A1 | MONOMERIC DIOLS AND PHOSPHATE LINKED OLIGOMERS FORMED THEREFROM | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-30 | — | — | EP | disclosed |
| EP-0673956-A1 | Binder for coating materials containing dispersed inorganic powder, coating material containing dispersed inorganic powder, and magnetic recording medium | NIPPON ZEON CO., LTD. (JP) | 1995-09-27 | — | — | EP | disclosed |
| WO-1995018820-A1 | MONOMERIC DIOLS AND PHOSPHATE LINKED OLIGOMERS FORMED THEREFROM | ISIS PHARMACEUTICALS, INC. (US) | 1995-07-13 | — | — | WO | disclosed |
| EP-0602209-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-22 | — | — | EP | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148699-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | PDE3B, PDE4A, PDE3A | ALDH1A1 234/4885PRKD3 1080/4885PRKCG 1372/4885 |
| US-20250243220-A1 | ATR INHIBITORS | ATR, CHEK1, CHEK2 | ALDH1A1 3467/4885PRKD3 145/4885PRKCG 286/4885 |
| US-20200078340-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | PDE3B, PDE4A, PDE3A | ALDH1A1 234/4885PRKD3 1080/4885PRKCG 1372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.